Share This Page
Drug Price Trends for GNP SINUS SEVERE CAPLET
✉ Email this page to a colleague

Average Pharmacy Cost for GNP SINUS SEVERE CAPLET
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
GNP SINUS SEVERE CAPLET | 46122-0412-62 | 0.11364 | EACH | 2025-01-22 |
GNP SINUS SEVERE CAPLET | 46122-0412-62 | 0.11597 | EACH | 2024-12-18 |
GNP SINUS SEVERE CAPLET | 46122-0412-62 | 0.11453 | EACH | 2024-11-20 |
GNP SINUS SEVERE CAPLET | 46122-0412-62 | 0.11741 | EACH | 2024-10-23 |
GNP SINUS SEVERE CAPLET | 46122-0412-62 | 0.11283 | EACH | 2024-09-18 |
GNP SINUS SEVERE CAPLET | 46122-0412-62 | 0.10857 | EACH | 2024-08-21 |
GNP SINUS SEVERE CAPLET | 46122-0412-62 | 0.11551 | EACH | 2024-07-17 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Sinus Severe Caplets: A Comprehensive Overview
Introduction to Sinus Severe Caplets
Sinus severe caplets, such as those offered by Tylenol, are designed to provide relief from symptoms associated with sinus congestion, headaches, and other respiratory allergies. These caplets typically contain a combination of active ingredients like acetaminophen, guaifenesin, and phenylephrine, which work together to alleviate pain, reduce congestion, and thin bronchial secretions[1][5].
Market Size and Growth
The market for sinusitis treatment, which includes products like sinus severe caplets, has been experiencing significant growth. As of 2023, the global sinusitis treatment market was valued at $2.78 billion and is projected to grow to $2.95 billion in 2024, with a compound annual growth rate (CAGR) of 6.1%. By 2028, the market is expected to reach $3.76 billion, driven by factors such as the rising prevalence of sinusitis, an increasing geriatric population, and advancements in treatment technologies[3].
Drivers of Market Growth
Increasing Prevalence of Sinusitis
The incidence of sinus infections is on the rise, affecting approximately 40% of the U.S. population. This increase is driven by various factors, including respiratory tract infections, compromised immunity, structural issues in the sinuses, and nasal polyps. The growing prevalence of sinusitis is a major driver for the demand of sinus severe caplets and other sinusitis treatment drugs[4].
Technological Advancements
Technological advancements in drug delivery systems, such as the development of nasal sprays, are also boosting the market. Innovations like Optinose XHANCE, which provide more effective and convenient ways to deliver medication directly to the sinuses, are gaining traction and investor attention[4].
Health Awareness and Government Support
Increased health awareness and government support for healthcare programs and research are additional factors contributing to the growth of the sinusitis treatment market. These initiatives help in improving diagnostic capabilities and treatment options, further driving the demand for products like sinus severe caplets[3].
Price Projections
Current Market Pricing
The pricing of sinus severe caplets can vary based on the brand, location, and distribution channel. However, these products generally fall within a competitive price range due to the presence of multiple market players. For instance, Tylenol Sinus Severe Daytime Caplets are typically priced in the range of $10 to $20 per package, depending on the size and retailer[1][5].
Future Pricing Trends
Given the projected growth of the sinusitis treatment market, prices are likely to remain competitive. However, several factors could influence future pricing:
- Technological Advancements: New drug delivery technologies and innovative products may command a premium price due to their enhanced efficacy and convenience.
- Generic and Branded Competition: The availability of generic alternatives could keep prices in check, while branded products with unique formulations or delivery systems might maintain or slightly increase their prices.
- Regulatory Changes: Any changes in regulatory policies, such as the proposed removal of oral phenylephrine from the OTC monograph by the FDA, could impact pricing strategies[1].
Market Segmentation
The sinusitis treatment market, including sinus severe caplets, can be segmented based on several criteria:
Type of Sinusitis
- Acute Sinusitis
- Sub-Acute Sinusitis
- Chronic Sinusitis
Each type has different treatment needs, which can influence the pricing and demand for specific products[4].
Treatment Options
- Analgesics
- Antihistamines
- Corticosteroids
- Antibiotics
- Sulphonamides
- Other treatments
The diversity in treatment options allows for a range of price points, catering to different patient needs and preferences[4].
Route of Administration
- Oral
- Topical
- Others
Innovations in nasal sprays and other topical treatments are expected to grow in popularity, potentially affecting the pricing dynamics of oral medications like sinus severe caplets[4].
End-Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
The distribution channel and end-user segment can also influence pricing, with hospital and specialty clinic settings often having different pricing structures compared to homecare and retail settings[4].
Key Takeaways
- The sinusitis treatment market is growing due to increasing prevalence, technological advancements, and health awareness.
- Sinus severe caplets are a significant part of this market, offering relief from sinus congestion and related symptoms.
- Future pricing will be influenced by technological innovations, regulatory changes, and competition from generic and branded products.
- Market segmentation based on type of sinusitis, treatment options, route of administration, and end-users will continue to shape the pricing and demand dynamics.
FAQs
Q: What are the active ingredients in Tylenol Sinus Severe Daytime Caplets? A: The active ingredients include acetaminophen (325 mg), guaifenesin (200 mg), and phenylephrine HCl (5 mg)[1].
Q: How is the sinusitis treatment market expected to grow in the next few years? A: The market is expected to grow from $2.78 billion in 2023 to $3.76 billion by 2028, with a CAGR of 6.2%[3].
Q: What are the major drivers of the sinusitis treatment market? A: The major drivers include the increasing prevalence of sinusitis, technological advancements, growing geriatric population, and increasing healthcare expenditure[3].
Q: How do technological advancements impact the pricing of sinus severe caplets? A: Technological advancements, such as new drug delivery systems, can lead to premium pricing for innovative products while keeping prices competitive for traditional formulations[4].
Q: What is the proposed FDA action on oral phenylephrine, and how might it affect the market? A: The FDA has proposed removing oral phenylephrine from the OTC monograph, which, if implemented, could influence the formulation and pricing of sinus severe caplets[1].
More… ↓